Fujian Aonong Biological Technology Grouporp (SHSE:603363) Total Assets : ¥12,600 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Fujian Aonong Biological Technology Grouporp Total Assets?

Fujian Aonong Biological Technology Grouporp's Total Assets for the quarter that ended in Mar. 2024 was ¥12,600 Mil.

Warning Sign:

If a company builds assets at 39.2% a year, faster than its revenue growth rate of 23.4% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Fujian Aonong Biological Technology Grouporp's average Total Assets Growth Rate was -31.40% per year. During the past 3 years, the average Total Assets Growth Rate was 2.00% per year. During the past 5 years, the average Total Assets Growth Rate was 39.20% per year. During the past 10 years, the average Total Assets Growth Rate was 45.00% per year.

During the past 11 years, Fujian Aonong Biological Technology Grouporp's highest 3-Year average Total Assets Growth Rate was 76.30%. The lowest was 2.00%. And the median was 42.50%.

Total Assets is connected with ROA %. Fujian Aonong Biological Technology Grouporp's annualized ROA % for the quarter that ended in Mar. 2024 was -8.91%. Total Assets is also linked to Revenue through Asset Turnover. Fujian Aonong Biological Technology Grouporp's Asset Turnover for the quarter that ended in Mar. 2024 was 0.18.

Fujian Aonong Biological Technology Grouporp Total Assets Historical Data

The historical data trend for Fujian Aonong Biological Technology Grouporp's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Aonong Biological Technology Grouporp Total Assets Chart

Fujian Aonong Biological Technology Grouporp Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

4,921.67

13,225.33

17,100.53

18,663.44

13,625.21

Fujian Aonong Biological Technology Grouporp Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															18,555.27	17,139.20	16,540.65	13,625.21	12,599.65

Fujian Aonong Biological Technology Grouporp Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Fujian Aonong Biological Technology Grouporp's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	-503.217	+	14128.43
	=	13,625

Fujian Aonong Biological Technology Grouporp's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	-862.35	+	13461.999
	=	12,600

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Total Assets Explanation

Total Assets is connected with ROA %.

Fujian Aonong Biological Technology Grouporp's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-1168.08	/	( (13625.213	+	12599.65)	/ 2 )
	=	-1168.08	/	13112.4315
	=	-8.91 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Fujian Aonong Biological Technology Grouporp's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	2407.845	/	( (13625.213	+	12599.65)	/ 2 )
=	2407.845	/	13112.4315
=	0.18

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Fujian Aonong Biological Technology Grouporp Total Assets Related Terms

Thank you for viewing the detailed overview of Fujian Aonong Biological Technology Grouporp's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Fujian Aonong Biological Technology Group Incorp Ltd (SHSE:603363) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

Guanyinshan Operation Center, 12th Floor, Building 10, Siming District, Fujian Province, Xiamen, CHN, 361008

Website

http://www.aonong.com.cn

Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.

Executives

Wu You Lin	Directors, senior managers
Huang Hua Dong	Director
Wen Qing Qi	Supervisors
Huang Zu Yao	Director
Lai Jun	senior management
Ye Jun Biao	Director
Yang Jing Quan	senior management
Ding Neng Shui	Director
Luo Zuo Ming	senior management
Hong Yuan Xiang	senior management
Guo Si Hu	senior management
Wu Jun	Director
Huang Ze Sen	senior management
Hou Hao Feng	senior management
Li Hai Feng	senior management

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Headlines

No Headlines